| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| sym013 | epidermal growth factor receptor | NA | Successful target | TTD , DGIDB | Epithelial ovarian cancer[MeSHID:C538090] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
NA | phase 1/2 | unknown |
| sym013 | erbb2 tyrosine kinase receptor | NA | Successful target | TTD , DGIDB | Epithelial ovarian cancer[MeSHID:C538090] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
NA | phase 1/2 | unknown |
| sym013 | erbb3 tyrosine kinase receptor | NA | Clinical trial target | TTD , DGIDB | Epithelial ovarian cancer[MeSHID:C538090] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
NA | phase 1/2 | unknown |
| click here to return to the previous page | ||||||||